Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanming Xie

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|September 9, 2010
[A discussion of key issues on postmarketing reevaluation of Chinese medicine]Yanming Xie, Feng Tian
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Literature review of post-marketing clinical evaluation of Xiaoke pill]Huan Liu, Yanming Xie
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Ethical consideration in several commonly used study design]Xiuqin Wang, Yanming Xie
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Design requirements for clinical trials on re-evaluation of safety and efficacy of post-marketed Chinese herbs]Yanming Xie, Xu Wei
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Post-marketing re-evaluation about usage and dosage of Chinese medicine based on human population pharmacokinetics]Junjie Jiang, Yanming Xie
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Guidance of FDA risk evaluation and mitigation strategy and enlightenment to drug risk management of post-marketing Chinese medicine]Yuanyuan Li, Yanming Xie
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Process and key points of clinical literature evaluation of post-marketing traditional Chinese medicine]Huan Liu, Yanming Xie
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Sample size calculation in clinical post-marketing evaluation of traditional Chinese medicine]Yingkun Fu, Yanming Xie
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|September 24, 2009
[Research on foreign countries laws and regulations on surveillance and reporting of postmarketing drugs adverse reactions]Feng Tian, Yanming Xie
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Explore method about post-marketing safety re-evaluation of Chinese patent medicines based on HIS database in real world]Wei Yang, Yanming Xie, Yan Zhuang
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|September 9, 2010
[A discussion of key issues on postmarketing reevaluation of Chinese medicine]Yanming Xie, Feng Tian
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Literature review of post-marketing clinical evaluation of Xiaoke pill]Huan Liu, Yanming Xie
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Ethical consideration in several commonly used study design]Xiuqin Wang, Yanming Xie
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Design requirements for clinical trials on re-evaluation of safety and efficacy of post-marketed Chinese herbs]Yanming Xie, Xu Wei
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Post-marketing re-evaluation about usage and dosage of Chinese medicine based on human population pharmacokinetics]Junjie Jiang, Yanming Xie
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Guidance of FDA risk evaluation and mitigation strategy and enlightenment to drug risk management of post-marketing Chinese medicine]Yuanyuan Li, Yanming Xie
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Process and key points of clinical literature evaluation of post-marketing traditional Chinese medicine]Huan Liu, Yanming Xie
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Sample size calculation in clinical post-marketing evaluation of traditional Chinese medicine]Yingkun Fu, Yanming Xie
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|September 24, 2009
[Research on foreign countries laws and regulations on surveillance and reporting of postmarketing drugs adverse reactions]Feng Tian, Yanming Xie
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 2, 2012
[Explore method about post-marketing safety re-evaluation of Chinese patent medicines based on HIS database in real world]Wei Yang, Yanming Xie, Yan Zhuang
Pageof 13